Nephro-Urology Monthly

Published by: Kowsar

Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis

Shiva Kalantari 1 , Mohsen Nafar 2 , 3 , 4 , * , Shiva Samavat 2 , 3 , 4 , Mostafa Rezaei-Tavirani 5 , Dorothea Rutishauser 6 , 7 and Roman Zubarev 6 , 7
Authors Information
1 Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
6 Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
7 SciLifeLab, Stockholm, Sweden
Article information
  • Nephro-Urology Monthly: March 01, 2014, 6 (2); e16806
  • Published Online: March 9, 2014
  • Article Type: Research Article
  • Received: December 11, 2013
  • Revised: December 29, 2013
  • Accepted: January 2, 2014
  • DOI: 10.5812/numonthly.16806

To Cite: Kalantari S, Nafar M, Samavat S, Rezaei-Tavirani M, Rutishauser D, et al. Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis, Nephro-Urol Mon. 2014 ; 6(2):e16806. doi: 10.5812/numonthly.16806.

Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994; 46(4): 1223-41[PubMed]
  • 2. Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol. 2003; 23(2): 161-71[DOI][PubMed]
  • 3. Benchimol C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr. 2003; 15(2): 171-80[PubMed]
  • 4. Schnaper HW. Idiopathic focal segmental glomerulosclerosis. Semin Nephrol. 2003; 23(2): 183-93[DOI][PubMed]
  • 5. Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int. 1999; 56(6): 2236-42[DOI][PubMed]
  • 6. Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, et al. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. PLoS One. 2013; 8(12)[DOI][PubMed]
  • 7. Kalantari S, Nafar M, Rutishuser D. Predictive Urinary Biomarkers for Steroid-resistant and Steroid-sensitive Focal Segmental Glomerulosclerosis Using High Resolution Mass Spectrometry and Multivariate Statistical Analysis. PLOS ONE. 2013;
  • 8. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemometric 2002; 16(3): 119-28[DOI]
  • 9. Hanamura K, Tojo A, Kinugasa S, Asaba K, Fujita T. The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int J Nephrol. 2012; 2012: 139565[DOI][PubMed]
  • 10. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80(1): 17-28[DOI][PubMed]
  • 11. Humphrey RL, Karpetsky TP, Neuwelt EA, Levy CC. Levels of serum ribonuclease as an indicator of renal insufficiency in patients with leukemia. Cancer Res. 1977; 37(7 Pt 1): 2015-22[PubMed]
  • 12. Bellei E, Cuoghi A, Monari E, Bergamini S, Fantoni LI, Zappaterra M, et al. Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages. J Headache Pain. 2012; 13(1): 45-52[DOI][PubMed]
  • 13. Costacou T, Ferrell RE, Ellis D, Orchard TJ. Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes. 2009; 58(12): 2904-9[DOI][PubMed]
  • 14. Flynn FV, Lapsley M, Sansom PA, Cohen SL. Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease. J Clin Pathol. 1992; 45(7): 561-7[PubMed]
  • 15. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007; 18(3): 913-22[DOI][PubMed]
  • 16. Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4(5)[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments